[HTML][HTML] A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast …

JS Baek, CW Cho - Oncotarget, 2017 - ncbi.nlm.nih.gov
The objective of the work was to develop a multifunctional nanomedicine based on a folate-
conjugated lipid nanoparticles loaded with paclitaxel and curcumin. The novel system …

A comparative study on micelles, liposomes and solid lipid nanoparticles for paclitaxel delivery

S Dattani, X Li, C Lampa, D Lechuga-Ballesteros… - International Journal of …, 2023 - Elsevier
The purpose of this work was to compare the in vitro and in vivo characteristics of LDV-
targeted lipid-based micelles, liposomes and solid lipid nanoparticles (SLN) to provide …

Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies

M Anwar, S Akhter, N Mallick, S Mohapatra… - Pharmacological …, 2016 - Elsevier
Cancer chemotherapeutic drug containing PEGylated lipidic nanocapsules (D-LNCs) were
formulated by the controlled addition of organic phase (combined solution of paclitaxel and …

In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells

G Niu, CH Castro, N Nguyen, SM Sullivan… - Journal of drug …, 2010 - Taylor & Francis
Cationic paclitaxel nanoparticles were developed and the possible delivery mechanism was
explored by cellular uptake studies. In vitro cytotoxicity of paclitaxel-loaded nanoparticles …

Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells

L Gao, G Liu, J Ma, X Wang, F Wang, H Wang… - Colloids and Surfaces B …, 2014 - Elsevier
Purpose The present studies evaluated the ability of paclitaxel (PTX) nanosuspension
coated with TPGS to reverse drug-resistance of P-glycoprotein (P-gp)-overexpressing H460 …

Combination of curcumin and paclitaxel liposomes exhibits enhanced cytotoxicity towards A549/A549-T cells and unaltered pharmacokinetics

X Feng, C Pi, S Fu, H Yang, X Zheng… - Journal of …, 2020 - ingentaconnect.com
Background: Combination chemotherapy of chemo-drugs and natural herbal drugs has
been shown to be more advantageous than individual treatment with respect to enhancing …

Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity

L Vicari, T Musumeci, I Giannone, L Adamo… - BMC cancer, 2008 - Springer
Background PTX is one of the most widely used drug in oncology due to its high efficacy
against solid tumors and several hematological cancers. PTX is administered in a …

[HTML][HTML] Targeting CD44-positive ovarian cancers via engineered paclitaxel prodrug nanoparticles for enhanced chemotherapeutic efficacy

X Sun, R Zhao, E Zhao, Q Wang, W Lian… - Biomedicine & …, 2022 - Elsevier
Ovarian cancer (OvCa) is currently the fifth most lethal malignancy affecting women health
owing to the lack of early diagnosis and treatment choices available before the disease has …

Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells

D Le Broc-Ryckewaert, R Carpentier, E Lipka… - International journal of …, 2013 - Elsevier
Taxanes, including paclitaxel, are anti-cancer drugs approved for the treatment of prostate
cancer but which have limited clinical application due to their hydrophobicity, their low …

Chitosan/pshRNA plasmid nanoparticles targeting MDR1 gene reverse paclitaxel resistance in ovarian cancer cells

Y Yang, Z Wang, M Li, S Lu - Journal of Huazhong University of Science …, 2009 - Springer
In order to investigate the effect of chitosan/pshRNA plasmid nanoparticles targeting MDR1
genes on the resistance of A2780/TS cells to paclitaxel, chitosan/pshRNA plasmid …